SLDB – solid biosciences inc. (US:NASDAQ)
Stock Stats
News
1/15
01:01 pm
sldb
Low
JPM26: Solid Biosciences banks on its AAV capsid to catalyse gene therapy success [Yahoo! Finance]
1/14
12:30 pm
sldb
Low
Solid Biosciences (NASDAQ:SLDB) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
1/14
03:53 am
sldb
High
Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101 [Yahoo! Finance]
1/13
04:15 pm
sldb
High
Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101
1/12
04:15 pm
sldb
Medium
Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia
11/3/2025
04:05 pm
SLDB
-15.3%
MISS
8/12/2025
04:07 pm
SLDB
10.6%
BEAT
1/14
12:30 pm
Reiterates
Buy
Buy
Needham & Company LLC
Low
0.4%
1/14
12:24 pm
Reiterates
Buy
Buy
Needham
Low
0.7%
1/14
12:24 pm
Reiterates
Buy
Buy
Needham
Low
0.7%
12/17
08:45 am
Reiterates
Market Outperform
Market Outperform
Citigroup Inc.
High
-10.5%
12/6
05:47 am
Upgrades
Moderate Buy
Needham & Company LLC
Low
-1.0%
1/13
05:03 pm
sldb
High
Form 4 Solid Biosciences Inc. For: Jan 09 Filed by: Tan Kevin
1/13
05:01 pm
sldb
High
Form 144 Solid Biosciences Inc. Filed by: Tan Kevin
1/7
04:05 pm
sldb
Medium
Form 4 Solid Biosciences Inc. For: Jan 02 Filed by: SMITH IAN F
1/6
06:52 pm
sldb
Medium
Form 4 Solid Biosciences Inc. For: Jan 03 Filed by: Ganot Ilan
12/4
04:22 pm
sldb
Low
Form 4 Solid Biosciences Inc. For: Dec 02 Filed by: Howton David T
Show more
Top News Gainers
7/26 Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors 34.4%
8/16 Solid Biosciences Inc (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $10.00 price target on the stock. 33.5%
8/14 Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update 23.8%
5/14 Solid Biosciences Inc (NASDAQ: SLDB) was downgraded by analysts at Chardan Capital from a "buy" rating to a "neutral" rating. They now have a $7.50 price target on the stock. 18.9%
10/11 Solid Biosciences Inc (NASDAQ: SLDB) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock. 11.2%
9/20 Solid Biosciences Inc (NASDAQ: SLDB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock. 11.2%
10/16 SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Solid Biosciences Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors 10.7%
7/29 Form 4 Solid Biosciences Inc. For: Jul 25 Filed by: Ganot Ilan 9.0%
8/27 Solid Biosciences Looks Like An Obvious Sell [Seeking Alpha] 8.7%
11/12 Solid Biosciences Inc (NASDAQ: SLDB) had its price target lowered by analysts at Credit Suisse Group AG from $6.00 to $2.00. They now have a "hold" rating on the stock. 7.4%
Top News Decliners
11/12 Solid Biosciences Provides SGT-001 Program Update -74.4%
5/13 Q1/2019 3/31/2019 EPS -0.850 ZacksConsensus -0.610 ActVsEst (0.240) - Miss -28.6%
3/13 Form 4 Solid Biosciences Inc. For: Mar 11 Filed by: Ziolkowski Jennifer Lynn -21.1%
12/18 Solid Biosciences stock are up on DMD study news [MarketWatch] -20.1%
1/9 Form 8-K Solid Biosciences Inc. For: Jan 07 -14.6%
3/23 Solid Biosciences Inc (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $5.00 price target on the stock. -9.3%
7/26 Form 8-K Solid Biosciences Inc. For: Jul 25 -9.2%
3/20 Solid Biosciences Inc (NASDAQ: SLDB) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -6.9%
8/29 Solid Biosciences Inc (NASDAQ: SLDB) was downgraded by analysts at Citigroup Inc from a "neutral" rating to a "sell" rating. They now have a $6.00 price target on the stock. -5.4%
7/31 Form D Solid Biosciences Inc. -5.3%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3